Axsome Therapeutics(AXSM) - 2023 Q4 - Earnings Call Transcript
Axsome Therapeutics(AXSM)2024-02-20 23:47
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2023 Earnings Conference Call February 20, 2024 8:00 AM ET Company Participants Mark Jacobson - Chief Operating Officer Herriot Tabuteau - Chief Executive Officer Nick Pizzie - Chief Financial Officer Ari Maizel - Executive Vice President and Head of Commercial Hunter Murdock - General Counsel Conference Call Participants Leonid Timashev - RBC Capital Markets Charles Duncan - Cantor Fitzgerald Ash Verma - UBS Jason Gerberry - Bank of America David Amsellem - Piper ...